A Re-challenge Safety Score Using IFN-γ ELISpot to Guide Essential Drug Reintroduction after Severe Cutaneous Adverse Reactions

Journal of Allergy and Clinical Immunology 2026

View at publisher

Authors: Nawaporn Chalermsuk, Jettanong Klaewsongkram, Yuda Chongpison

DOI: 10.1016/j.jaci.2025.12.292

Cited by: 0

Fields of Study & Subjects

Drug-Induced Adverse Reactions Pharmacovigilance and Adverse Drug Reactions Contact Dermatitis and Allergies